| Autor: |
Rivina L, Davoren M; Department of Environmental Health Sciences, University of California, Los Angeles, 650 Charles E, Young Dr, South, CHS 71-295, Los Angeles, CA 90095, USA. mdavoren@ucla.edu., Schiestl RH |
| Jazyk: |
angličtina |
| Zdroj: |
Human genomics [Hum Genomics] 2014 Jul 25; Vol. 8, pp. 13. Date of Electronic Publication: 2014 Jul 25. |
| DOI: |
10.1186/1479-7364-8-13 |
| Abstrakt: |
The use of radiation therapy is a cornerstone of modern cancer treatment. The number of patients that undergo radiation as a part of their therapy regimen is only increasing every year, but this does not come without cost. As this number increases, so too does the incidence of secondary, radiation-induced neoplasias, creating a need for therapeutic agents targeted specifically towards incidence reduction and treatment of these cancers. Development and efficacy testing of these agents requires not only extensive in vitro testing but also a set of reliable animal models to accurately recreate the complex situations of radiation-induced carcinogenesis. As radiation-induced leukemic progression often involves genomic changes such as rearrangements, deletions, and changes in methylation, the laboratory mouse Mus musculus, with its fully sequenced genome, is a powerful tool in cancer research. This fact, combined with the molecular and physiological similarities it shares with man and its small size and high rate of breeding in captivity, makes it the most relevant model to use in radiation-induced leukemia research. In this work, we review relevant M. musculus inbred and F1 hybrid animal models, as well as methods of induction of radiation-induced myeloid leukemia. Associated molecular pathologies are also included. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Full text from SpringerLink